Xvivo Perfusion AB (publ) (LON:0RKL)
London
· Delayed Price · Currency is GBP · Price in SEK 459.50
-3.84 (-0.83%)
At close: Feb 21, 2025
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 1.07 billion as of February 21, 2025. Its market cap has increased by 69.50% in one year.
Market Cap
1.07B
Enterprise Value
1.05B
Revenue
59.36M
Ranking
n/a
PE Ratio
86.38
Stock Price
459.50
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 34.98M to 1.07B, an increase of 2,968.71%. That is a compound annual growth rate of 31.86%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |